Zhang et al., for instance, discovered that a multikinase inhibitor targeting both FLT3 and BTK effectively overcame FLT3 inhibitor resistance in AML PDXs, which was mediated by autophagy[60]. The gene discussed is FLT3; the disease is acute myeloid leukemia.